Zogenix

^{, Nasdaq: ZGNX}

Recently launched Sumavel DosePro, a needle-free injectable migraine treatment.

Industry: Health Care

First Day Return: -0.5%

ZGNX

Recently launched Sumavel DosePro, a needle-free injectable migraine treatment.

IPO News for Zogenix

US IPO market slows pace in shortened holiday week with four tepid debuts 11/26/10
Chinese real estate agency services provider SYSWIN prices IPO at $7 per ADS; raises $67 million 11/23/10
Zogenix prices IPO at $4, raises $56 million to fund drug development 11/22/10

IPO Data
IPO Date	11/22/2010
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$56
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.zogenix.com
Headquarters	San Diego, CA, United States
Founded	2006
Employees at IPO	145

IPO News for Zogenix

Zogenix (ZGNX) Performance